| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Cidara Therapeutics, Inc.
13G/A
CDTX · 171757206
|
0% |
8/14/2025
Event 6/30/2025
|
||||
| Canaan XII L.P. | 0% | |||||
| Canaan Partners XII LLC | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.